INDUSTRY NEWS
On July 13, the National Joint Drug Procurement Office announced the preliminary result for the bid of the 7th round of volume-based procurement (VBP)…
In the first half of 2022, China National Medical Products Administration (NMPA) approved 210 domestically-manufactured generic drugs for marketing au…
Editor’s Notes: New drugs in this article refer to Innovative/improved new chemical drugs / biological products that have never been granted mar…
This is a collection of China’s recent pharmaceutical laws, regulations, policies, and standards, mainly issued by the following authorities: Na…
On June 1, China Center for Drug Evaluation (CDE) released the 2021 China Drug Evaluation Report. ChemLinked BaiPharm Team selected excerpts from the …
On June 29, 2022, China National Healthcare Security Administration (NHSA) issued the Work Plan for Adjusting the 2022 National Reimbursement Drug Lis…
On June 26, 2022, China Center for Food and Drug Inspections (CFDI), a public institution under National Medical Products Administration (NMPA), issue…
On June 20, China National Joint Drug Procurement Office announced the start of the 7th round of volume-based procurement (VBP), covering 59 drugs wit…
On June 2, China National Medical Products Administration (NMPA) released the draft of Good Manufacturing Practice of Pharmaceutical Packaging Materia…
As more sodium hyaluronate products emerge on the market, China is going to update its regulations to better guide the registration and supervision of…